Search details
1.
The EASEMENT study: A multicentre, observational, cross-sectional study to evaluate patient preferences, treatment satisfaction, quality of life, and healthcare resource use in patients with multiple myeloma receiving injectable-containing or fully oral therapies.
Eur J Haematol
; 112(6): 889-899, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38389468
2.
Acquired haemophilia A: A 15-year population-based review of incidence rate, patient demographics and treatment outcomes.
Haemophilia
; 29(5): 1269-1275, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37639377
3.
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis.
Eur J Haematol
; 111(5): 815-823, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37574220
4.
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients.
Br J Cancer
; 126(5): 718-725, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34802051
5.
Outcomes of daratumumab in the treatment of multiple myeloma: A retrospective cohort study from the Canadian Myeloma Research Group Database.
Br J Haematol
; 198(1): 93-102, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35383886
6.
Real-world outcomes with bortezomib-containing regimens and lenalidomide plus dexamethasone for the treatment of transplant-ineligible multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group database.
Br J Haematol
; 193(3): 532-541, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33559897
7.
Retrospective study of treatment patterns and outcomes post-lenalidomide for multiple myeloma in Canada.
Eur J Haematol
; 107(4): 416-427, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34129703
8.
The impact of lenalidomide maintenance on second-line chemotherapy in transplant eligible patients with multiple myeloma.
Eur J Haematol
; 106(5): 673-681, 2021 May.
Article
in English
| MEDLINE | ID: mdl-33539037
9.
A multicenter review of infusion-related reactions to daratumumab for relapsed multiple myeloma in the real world setting.
J Oncol Pharm Pract
; 27(4): 907-910, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33108988
10.
Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma.
Blood
; 132(24): 2546-2554, 2018 12 13.
Article
in English
| MEDLINE | ID: mdl-30352784
11.
Distinct and shared three-dimensional chromosome organization patterns in lymphocytes, monoclonal gammopathy of undetermined significance and multiple myeloma.
Int J Cancer
; 140(2): 400-410, 2017 Jan 15.
Article
in English
| MEDLINE | ID: mdl-27711972
12.
XPO1 Inhibition Preferentially Disrupts the 3D Nuclear Organization of Telomeres in Tumor Cells.
J Cell Physiol
; 231(12): 2711-9, 2016 12.
Article
in English
| MEDLINE | ID: mdl-26991404
13.
The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database.
Haematologica
; 106(6): 1733-1736, 2021 06 01.
Article
in English
| MEDLINE | ID: mdl-33054120
14.
Platelet microparticles and cancer: An intimate cross-talk.
Transfus Apher Sci
; 53(2): 168-72, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26542350
15.
Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial.
Cancer
; 120(2): 181-9, 2014 Jan 15.
Article
in English
| MEDLINE | ID: mdl-24127364
16.
Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial.
Nat Med
; 30(2): 543-551, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38177852
17.
Successful treatment of non-Hodgkin lymphoma associated immune thrombocytopenia with involved field radiotherapy.
Hematol Oncol
; 31(4): 218-20, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-23606442
18.
First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium.
Clin Lymphoma Myeloma Leuk
; 23(5): 340-354, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36925389
19.
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database.
Blood Cancer J
; 13(1): 137, 2023 09 05.
Article
in English
| MEDLINE | ID: mdl-37669949
20.
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
Blood Cancer J
; 13(1): 111, 2023 07 20.
Article
in English
| MEDLINE | ID: mdl-37474492